Hutch News
Results per Page:
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell
After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
Failed Alzheimer’s drug boosts CAR T-cell therapy
Engineered immune cells get a helping hand in new clinical trial for multiple myeloma patients
Eliminating residual multiple myeloma with precision
From the Green Lab, Clinical Research Division
“Exciting” but early results in trial of immunotherapy for myeloma
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease
3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant
$20M renewal of 4-decade-long federal grant to Hutch scientists
Pretargeting redux: A bispecific antibody re-ignites radioimmunotherapy
From the Green lab, Clinical Research Division
Good News: Fred Hutch joins coalition that seeks to increase transparency on life science career prospects
Celebrating faculty and staff achievements
Good News: Damian Green awarded $3.2M to test radioimmunotherapy for multiple myeloma ... and more
Celebrating faculty and staff achievements
Hematology oncologist Green joins Clinical Research faculty
Former Center postdoc Damian Green aims to improve delivery of new therapies from lab to multiple myeloma, lymphoma patients